Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines
Go back to Vanda Pharmaceuticals Calls on FDA to Withdraw Proposal from FY 2027 Legislative Agenda That Would Extend Drug Review Timelines| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 6.03 +0.03 (0.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.00 | 52 Week High | $18.00 | |||
| Open | $5.97 | 52 Week Low | $6.91 | |||
| Day High | $6.11 | P/E | N/A | |||
| Day Low | $5.96 | EPS | $-0.67 | |||
| Volume | 332,244 | |||||
